Evidence map›Paper›PMID 36721741›Full record

ArticleZeitschrift fur Gesundheitswissenschaften = Journal of public health2023

Determinants of COVID-19 cases and deaths in OECD countries.

Burak Tekerek, Meliha Melis Günaltay, Gökcen Ozler, Meryem Turgut

Open access · bronzeAbstract read
In one paragraph

Article in Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Burak TekerekDepartment of Health Management, Faculty of Health Sciences, Yüksek Ihtisas University, Ankara, Turkey.ORCID https://orcid.org/0000-0001-7617-2368
Meliha Melis GünaltayDepartment of Health Management, Faculty of Health Sciences, Ankara University, Ankara, Turkey.ORCID https://orcid.org/0000-0002-2883-4416
Gökcen OzlerDepartment of Health Management, Faculty of Health Sciences, Ankara University, Ankara, Turkey.ORCID https://orcid.org/0000-0003-3099-5654
Meryem TurgutDepartment of Health Management, Zübeyde Hanım Faculty of Health Sciences, Nigde Omer Halisdemir University, Ataturk Boulevard, Derbent Campus (Opposite Hayat Hospital), Nigde, Turkey.ORCID 0000-0001-9320-3250
Ankara University · TRNiğde Ömer Halisdemir Üniversitesi · TRYüksek İhtisas Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: This research aims to examine the effects of variables that can affect COVID-19 deaths and cases in Organisation for Economic Co-operation and Development (OECD) countries during the years 2020 (first wave), 2021 (vaccine available), and 2022 (vaccine available and Omicron variant appeared). Material and method: The factors that are thought to affect the case and death rates in 37 OECD countries were examined by multiple linear regression analysis using SPSS 22. The dependent variables were the COVID-19 deaths and cases per 10,000 (in 2020, 2021, and 2022); the independent variables were universal health coverage, physicians, nurses, intensive care beds, hospital beds, non-communicable diseases mortality per 100,000 people, population over 65 years of age, out-of-pocket expenditure, private expenditure, and health expenditure per capita and percent of % GDP. Results: It was determined that the non-communicable diseases mortality is the relatively important variable COVID-19 cases and deaths in 2020 and 2021. After controlling for the scores of other variables, according to the ß coefficients, a one-unit increase in the number of physicians variable increases COVID-19 cases by 1.14 units in 2022; a one-unit increase in the universal coverage variable decreases COVID-19 deaths by 0.33 units in 2022. Conclusion: The results of this research provide evidence that the effects of the COVID-19 outbreak have changed between 2020, the first wave of the epidemic, 2021, when the vaccine is available, and 2022, when both the vaccine is available and the Omicron variant is seen. With the increase in vaccination in 2022, the impact of non-communicable diseases mortality on the number of COVID-19 cases has decreased.

Indexed as

COVID-19Health expendituresHealth resourcesNoncommunicable diseases

Identifiers

PMID36721741
PMCPMC9880371
OpenAlexW4318183154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.